Faculty Profiles - SUZUKI Nobuaki

Papers - SUZUKI Nobuaki

Division display 1 - 20 of about 52 ／ All the affair displays >>

Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance

Ohara, F; Suzuki, A; Suzuki, N; Kanematsu, T; Okamoto, S; Tamura, S; Kiyoi, H; Matsushita, T; Katsumi, A

INTERNATIONAL JOURNAL OF HEMATOLOGY 2024.9

Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy

Shima, M; Suzuki, N; Nishikii, H; Amano, K; Ogawa, Y; Kobayashi, R; Ozaki, R; Yoneyama, K; Mizuno, N; Sakaida, E; Saito, M; Okamura, T; Ito, T; Hattori, N; Higasa, S; Seki, Y; Nogami, K

THROMBOSIS AND HAEMOSTASIS 2024.9

Variability in combinations of APTT reagent and substrate plasma for a one-stage clotting assay to measure factor VIII products

Suzuki, A; Suzuki, N; Kanematsu, T; Okamoto, S; Suzuki, N; Tamura, S; Kikuchi, R; Katsumi, A; Kojima, T; Matsushita, T

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Vol. 46 ( 4 ) page： 705 - 713 2024.8

Basement membrane extract potentiates the endochondral ossification phenotype of bone marrow-derived mesenchymal stem cell-based cartilage organoids

Notoh, H; Yamasaki, S; Suzuki, N; Suzuki, A; Okamoto, S; Kanematsu, T; Suzuki, N; Katsumi, A; Kojima, T; Matsushita, T; Tamura, S

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 701 2024.3

Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study

Nogami, K; Fujii, T; Sawada, A; Nagao, A; Nagae, C; Nojima, M; Suzuki, N; Nosaka, D; Shimura, T; Sugao, Y; Amano, K

INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 119 ( 1 ) page： 14 - 23 2024.1

AKATSUKI 48-Week Interim Analysis: Emicizumab and Immune Tolerance Induction in People with Hemophilia A and Factor VIII Inhibitors

Matsushita, T; Suzuki, N; Nagae, C; Nagao, A; Ando, M; Kuwatsuka, Y; Nosaka, D; Kyogoku, Y; Shimura, T; Nogami, K

BLOOD Vol. 142 2023.11

Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data

Nagao Azusa, Chikasawa Yushi, Sawada Akihiro, Kanematsu Takeshi, Yamasaki Naoya, Takedani Hideyuki, Nojima Masanori, Fujii Teruhisa, Suzuki Nobuaki, Matsushita Tadashi, Higasa Satoshi, Amano Kagehiro, ADVANCE Japan Working Grp

HAEMOPHILIA 2023.10

A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A

Shima Midori, Amano Kagehiro, Ogawa Yoshiyuki, Yoneyama Koichiro, Ozaki Ryoto, Kobayashi Ryota, Sakaida Emiko, Saito Makoto, Okamura Takashi, Ito Toshihiro, Hattori Norimichi, Higasa Satoshi, Suzuki Nobuaki, Seki Yoshinobu, Nogami Keiji

JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 21 ( 3 ) page： 534 - 545 2023.3

The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients

Suzuki Naruko, Suzuki Nobuaki, Kawaguchi Yuka, Okamoto Shuichi, Kanematsu Takeshi, Katsumi Akira, Suzuki Atsuo, Tamura Shogo, Kojima Tetsuhito, Kiyoi Hitoshi, Matsushita Tadashi

THROMBOSIS JOURNAL Vol. 21 ( 1 ) page： 10 2023.1

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

Kashiwakura Yuji, Baatartsogt Nemekhbayar, Yamazaki Shoji, Nagao Azusa, Amano Kagehiro, Suzuki Nobuaki, Matsushita Tadashi, Sawada Akihiro, Higasa Satoshi, Yamasaki Naoya, Fujii Teruhisa, Ogura Taemi, Takedani Hideyuki, Taki Masashi, Matsumoto Takeshi, Yamanouchi Jun, Sakai Michio, Nishikawa Masako, Yatomi Yutaka, Yada Koji, Nogami Keiji, Watano Ryota, Hiramoto Takafumi, Hayakawa Morisada, Kamoshita Nobuhiko, Kume Akihiro, Mizukami Hiroaki, Ishikawa Shizukiyo, Sakata Yoichi, Ohmori Tsukasa

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT Vol. 27 page： 404 - 414 2022.12

Efficacy and Safety of Emicizumab Prophylaxis in Patients with Acquired Hemophilia a Who Were Deemed Ineligible for Immunosuppressive Therapy: Additional Data from the Ageha Study

Nishikii Hidekazu, Suzuki Nobuaki, Kobayashi Ryota, Mizuno Narumi, Ozaki Ryoto, Shima Midori

BLOOD Vol. 140 page： 2724 - 2725 2022.11

VWF-Gly2752Ser, a novel non-cysteine substitution variant in the CK domain, exhibits severe secretory impairment by hampering C-terminal dimer formation

Okamoto Shuichi, Tamura Shogo, Sanda Naomi, Odaira Koya, Hayakawa Yuri, Mukaide Masato, Suzuki Atsuo, Kanematsu Takeshi, Hayakawa Fumihiko, Katsumi Akira, Kiyoi Hitoshi, Kojima Tetsuhito, Matsushita Tadashi, Suzuki Nobuaki

JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 20 ( 8 ) page： 1784 - 1796 2022.8

TSUBASA: A prospective study evaluating the association between physical activity and bleeding events in people with haemophilia A during emicizumab prophylaxis

Fujii Teruhisa, Amano Kagehiro, Sawada Akihiro, Nagao Azusa, Nagae Chiai, Nojima Masanori, Suzuki Nobuaki, Nosaka Daisuke, Shimura Tomomi, Sugao Yoshimasa, Nogami Keiji

HAEMOPHILIA Vol. 28 page： 24 - 25 2022.5

F9mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B

Odaira Koya, Kawashima Fumika, Tamura Shogo, Suzuki Nobuaki, Tokoro Mahiru, Hayakawa Yuri, Suzuki Atsuo, Kanematsu Takeshi, Okamoto Shuichi, Takagi Akira, Katsumi Akira, Matsushita Tadashi, Shima Midori, Nogami Keiji, Kojima Tetsuhito, Hayakawa Fumihiko

THROMBOSIS RESEARCH Vol. 213 page： 91 - 96 2022.5

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors

Matsushita Tadashi, Suzuki Nobuaki, Nagao Azusa, Nagae Chiai, Yamaguchi-Suita Haruko, Kyogoku Yui, Ioka Akiko, Nogami Keiji

BMJ OPEN Vol. 12 ( 3 ) page： e057018 2022.3

Protein S-Leu17Pro disrupts the hydrophobicity of its signal peptide causing a proteasome-dependent degradation

Okada Kentaro, Tamura Shogo, Suzuki Nobuaki, Odaira Koya, Mukaide Masato, Fujii Wataru, Katsuragi Yumi, Suzuki Atsuo, Kanematsu Takeshi, Okamoto Shuichi, Suzuki Naruko, Katsumi Akira, Matsushita Tadashi, Kojima Tetsuhito, Hayakawa Fumihiko

THROMBOSIS RESEARCH Vol. 210 page： 26 - 32 2022.2

Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis

Suzuki Atsuo, Suzuki Nobuaki, Kanematsu Takeshi, Shinohara Sho, Kurono Hiroshi, Arai Nobuo, Okamoto Shuichi, Suzuki Naruko, Tamura Shogo, Kikuchi Ryosuke, Katsumi Akira, Kojima Tetsuhito, Matsushita Tadashi

SCIENTIFIC REPORTS Vol. 12 ( 1 ) page： 434 2022.1

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia HCC after HCV eradication in hemophilia

Inukai Yosuke, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

ANNALS OF HEPATOLOGY Vol. 27 ( 1 ) page： 100545 2022

Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs

Yamamoto Takafumi, Imai Norihiro, Yamamoto Kenta, Ito Takanori, Ishizu Yoji, Honda Takashi, Okamoto Shuichi, Kanematsu Takeshi, Suzuki Nobuaki, Matsushita Tadashi, Ishigami Masatoshi, Fujishiro Mitsuhiro

ANTICANCER RESEARCH Vol. 41 ( 5 ) page： 2569 - 2573 2021.5

Essential role of a carboxyl-terminal α-helix motif in the secretion of coagulation factor XI

Hayakawa Yuri, Tamura Shogo, Suzuki Nobuaki, Odaira Koya, Tokoro Mahiru, Kawashima Fumika, Hayakawa Fumihiko, Takagi Akira, Katsumi Akira, Suzuki Atsuo, Okamoto Shuichi, Kanematsu Takeshi, Matsushita Tadashi, Kojima Tetsuhito

JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 19 ( 4 ) page： 920 - 930 2021.4

　 PREV - NEXT 　

<SUZUKI Nobuaki>

Papers - SUZUKI Nobuaki